BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND HLA-A, P01892, 3105, ENSG00000206503, P16188, P30447, P13746, P04439 AND Clinical Outcome
5 results:

  • 1. Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.
    Zou J; Ciurea SO; Kongtim P; Yi M; Carmazzi Y; Rondon G; Srour S; Partlow D; Champlin RE; Cao K
    Blood Adv; 2020 Aug; 4(15):3474-3485. PubMed ID: 32726398
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy.
    Sinn BV; Weber KE; Schmitt WD; Fasching PA; Symmans WF; Blohmer JU; Karn T; Taube ET; Klauschen F; Marmé F; Schem C; Stickeler E; Ataseven B; Huober J; von Minckwitz G; Seliger B; Denkert C; Loibl S
    Breast Cancer Res; 2019 Dec; 21(1):142. PubMed ID: 31829264
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.
    Shindo Y; Hazama S; Suzuki N; Iguchi H; Uesugi K; Tanaka H; Aruga A; Hatori T; Ishizaki H; Umeda Y; Fujiwara T; Ikemoto T; Shimada M; Yoshimatsu K; Takenouchi H; Matsui H; Kanekiyo S; Iida M; Koki Y; Arima H; Furukawa H; Ueno T; Yoshino S; Fujita T; Kawakami Y; Nakamura Y; Oka M; Nagano H
    J Exp Clin Cancer Res; 2017 Feb; 36(1):36. PubMed ID: 28241889
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Development of Peptide Vaccines for Triple-Negative breast cancer Treatment].
    Toh U; Saku S; Okabe M; Iwakuma N; Kimitsuki Y; Akashi M; Ogo E; Yamada A; Shichijo S; Itoh K; Akagi Y
    Gan To Kagaku Ryoho; 2016 Oct; 43(10):1249-1251. PubMed ID: 27760950
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2.
    Svane IM; Pedersen AE; Nikolajsen K; Zocca MB
    Vaccine; 2008 Aug; 26(36):4716-24. PubMed ID: 18616968
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.